Akso Health Group
AHG · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $15 | $2 | $13 | $6 |
| % Growth | 512.1% | -81.7% | 119.7% | – |
| Cost of Goods Sold | $15 | $2 | $12 | $5 |
| Gross Profit | -$0 | $0 | $1 | $1 |
| % Margin | -1.9% | 5.1% | 9.6% | 10.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4 | $9 | $16 | $3 |
| SG&A Expenses | $4 | $9 | $16 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $162 | $0 | $0 | $0 |
| Operating Expenses | $166 | $9 | $16 | $4 |
| Operating Income | -$166 | -$9 | -$14 | -$3 |
| % Margin | -1,125.4% | -357.8% | -108.2% | -54.3% |
| Other Income/Exp. Net | $0 | -$0 | $1 | -$1 |
| Pre-Tax Income | -$166 | -$9 | -$13 | -$4 |
| Tax Expense | -$31 | $0 | $0 | $0 |
| Net Income | -$135 | -$9 | -$1 | -$17 |
| % Margin | -913.4% | -391.8% | -10.3% | -280.8% |
| EPS | -0.48 | -0.45 | -0.06 | -2.55 |
| % Growth | -6.7% | -650% | 97.6% | – |
| EPS Diluted | -0.48 | -0.39 | -0.06 | -2.55 |
| Weighted Avg Shares Out | 285 | 21 | 8 | 7 |
| Weighted Avg Shares Out Dil | 285 | 24 | 8 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $2 | $0 | $0 | $0 |
| EBITDA | -$2 | -$9 | -$14 | -$3 |
| % Margin | -12% | -357.8% | -108.2% | -53.1% |